Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Shares Outstanding (2021 - 2025)

Bioregenx (BRGX) has 5 years of Shares Outstanding data on record, last reported at $3800.0 in Q1 2025.

  • For Q1 2025, Shares Outstanding changed 0.0% year-over-year to $3800.0; the TTM value through Mar 2025 reached $3800.0, changed 0.0%, while the annual FY2024 figure was $1.9 million, 99.75% down from the prior year.
  • Shares Outstanding reached $3800.0 in Q3 2025 per BRGX's latest filing, roughly flat from $3800.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $960.3 million in Q1 2025 and bottomed at $3800.0 in Q4 2023.
  • Average Shares Outstanding over 5 years is $372.3 million, with a median of $5.0 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: crashed 99.92% in 2023, then surged 25171744.74% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $269.7 million in 2021, then soared by 181.64% to $759.7 million in 2022, then rose by 1.46% to $770.8 million in 2023, then tumbled by 99.75% to $1.9 million in 2024, then crashed by 99.8% to $3800.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $3800.0 in Q1 2025, $1.9 million in Q4 2024, and $956.5 million in Q3 2024.